Intended for US audiences only.
DANYELZA® (naxitamab-gqgk)
40 mg/10 mL INJECTION
40 mg/10 mL INJECTION
Monday through Friday 8AM to 8PM ET at 1-833-33YMABS (1-833-339-6227), option (2)
Monday through Friday 8AM to 8PM ET at 1-833-33YMABS (1-833-339-6227), option (2)
Please click for full Prescribing Information and Patient Information for DANYELZA including Boxed Warning on serious infusion-related reactions and nervous system problems, and talk to your doctor.
Jump to health care professional section
Monday through Friday 8AM to 8PM ET at 1-833-33YMABS (1-833-339-6227), option (2)
If you are uninsured or need help affording DANYELZA, click on one of the options below to learn more about what assistance may be available to you.
If you have commercial or private insurance, you may be eligible* for the Co-pay Program. This program could help reduce out-of-pocket costs of DANYELZA to $0 for eligible patients.
Patients must be enrolled in Y-mAbs Connect for this program. Eligibility criteria include but are not limited to patients who have commercial or private insurance, are U.S. or U.S. territory residents, and are actively insured at time of treatment. Government- or publicly-insured patients are not eligible.
Please click here to download eligibility criteria and terms and conditions.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
If you are uninsured or are rendered underinsured for DANYELZA through your health plan, you may be eligible* for the PAP. This program may be able to provide DANYELZA to eligible patients at no cost.
Patients must be enrolled in Y-mAbs Connect and must meet certain eligibility criteria for this program.
Please click here to download eligibility criteria.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
Y-mAbs Connect case managers can provide information about other available third-party organizations that may provide financial support for certain out-of-pocket responsibilities for qualifying patients.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
Y-mAbs Connect case managers can provide information about additional support available through third-party organizations that may provide travel support such as lodging and travel costs to infusion site.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
If you are prescribed DANYELZA, your doctor can complete the Y-mAbs Connect Enrollment Form with you and return it by fax or mail.* A Y-mAbs Connect case manager will contact you once you have been enrolled.
Download the Y-mAbs Connect Enrollment Form under the “Administrative form” section
Fax or mail contact information can be found on the enrollment form.
If you are uninsured or need help affording DANYELZA, click on one of the options below to learn more about what assistance may be available to you.
If you have commercial or private insurance, you may be eligible* for the Co-pay Program. This program could help reduce out-of-pocket costs of DANYELZA to $0 for eligible patients.
Patients must be enrolled in Y-mAbs Connect for this program. Eligibility criteria include but are not limited to patients who have commercial or private insurance, are U.S. or U.S. territory residents, and are actively insured at time of treatment. Government- or publicly-insured patients are not eligible.
Please click here to download eligibility criteria and terms and conditions.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
If you are uninsured or are rendered underinsured for DANYELZA through your health plan, you may be eligible* for the PAP. This program may be able to provide DANYELZA to eligible patients at no cost.
Patients must be enrolled in Y-mAbs Connect and must meet certain eligibility criteria for this program.
Please click here to download eligibility criteria.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
Y-mAbs Connect case managers can provide information about other available third-party organizations that may provide financial support for certain out-of-pocket responsibilities for qualifying patients.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
Y-mAbs Connect case managers can provide information about additional support available through third-party organizations that may provide travel support such as lodging and travel costs to infusion site.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
If you are prescribed DANYELZA, your doctor can complete the Y-mAbs Connect Enrollment Form with you and return it by fax or mail.* A Y-mAbs Connect case manager will contact you once you have been enrolled.
Download the Y-mAbs Connect Enrollment Form under the “Administrative form” section.
Fax or mail contact information can be found on the enrollment form.
Case managers can conduct a benefits investigation to help understand your patient’s insurance coverage and out-of-pocket costs for DANYELZA.
Case managers can work with your patient’s insurer to determine PA requirements and track the progress of the PA outcome.
If your patient’s PA is denied, case managers can work with your patient’s insurer to determine the requirements for an appeal and track progress of appeals submission.
Download the Sample Letter of Medical Necessity and Sample Letter of Appeal in the “Downloadable information” section.
The Y-mAbs FRM is your liaison to Y-mAbs Connect in matters related to insurance and reimbursement.
The FRM can answer any relevant questions prior to and along the benefits investigation, PA, and appeals process. Any billing, coding, and reimbursement-related questions can also be directed towards the FRM.
Call Y-mAbs Connect at 1-833-33YMABS ( 1-833-339-6227 ), option 2 and ask to be connected to an FRM.
Download the Billing and Coding Guide under the “Downloadable information” section.
If your patient has commercial or private insurance, they may be eligible* for the Co-pay Program. This program could help reduce out-of-pocket costs of DANYELZA to $0 for eligible patients.
Patients must be enrolled in Y-mAbs Connect for this program. Eligibility criteria include but are not limited to patients who have commercial or private insurance, are U.S. or U.S. territory residents, and are actively insured at time of treatment. Government- or publicly-insured patients are not eligible.
Please click here to download eligibility criteria and terms and conditions.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
If your patient is uninsured or rendered underinsured for DANYELZA through their health plan, they may be eligible* for the PAP. This program may be able to provide DANYELZA to eligible patients at no cost.
Patients must be enrolled in Y-mAbs Connect and must meet certain eligibility criteria for this program.
Please click here to download eligibility criteria.
Note: Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue this program and any support provided to the patient.
Y-mAbs Connect case managers can provide information about other available third-party organizations that may provide financial support for certain out-of-pocket responsibilities for qualifying patients.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
Y-mAbs Connect case managers can provide information about additional support available through third-party organizations that may provide travel support such as lodging and travel costs to infusion site.
Note: Third-party organizations are not associated with Y-mAbs Therapeutics, Inc.; specific details and eligibility requirements may vary by organization.
Steps to getting your patient started on DANYELZA:
Enroll your patient in Y-mAbs Connect prior to ordering DANYELZA
Download the Y-mAbs Connect Enrollment Form under the “Administrative form” section
Note: Completing and returning an enrollment form does not require a commitment to prescribe or order DANYELZA.
DANYELZA is distributed to infusion sites through a limited specialty distributor network.
Download the How to Order DANYELZA Form under the “Downloadable information” section
Please click for full
Prescribing Information and Patient Information for DANYELZA including
Boxed Warning on serious infusion-related reactions and neurotoxicity.
Y-mAbs Connect Enrollment Form